Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Ingevity (NGVT) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $52.1 million.

  • Ingevity's Operating Expenses rose 991.56% to $52.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $424.3 million, marking a year-over-year increase of 676.9%. This contributed to the annual value of $381.0 million for FY2024, which is 121.86% down from last year.
  • Ingevity's Operating Expenses amounted to $52.1 million in Q3 2025, which was up 991.56% from $73.9 million recorded in Q2 2025.
  • Over the past 5 years, Ingevity's Operating Expenses peaked at $235.2 million during Q4 2024, and registered a low of $47.4 million during Q3 2024.
  • For the 5-year period, Ingevity's Operating Expenses averaged around $79.0 million, with its median value being $63.0 million (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 15852.19% in 2023, then crashed by 4597.6% in 2025.
  • Ingevity's Operating Expenses (Quarter) stood at $59.2 million in 2021, then increased by 11.99% to $66.3 million in 2022, then soared by 158.52% to $171.4 million in 2023, then skyrocketed by 37.22% to $235.2 million in 2024, then tumbled by 77.85% to $52.1 million in 2025.
  • Its Operating Expenses stands at $52.1 million for Q3 2025, versus $73.9 million for Q2 2025 and $63.1 million for Q1 2025.